← Back to Search

Contact Lens

DAILIES TOTAL1 Contact Lenses for Near-Sightedness (FOX Trial)

N/A
Recruiting
Led By Lyndon Jones, PhD, FCOptom
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 14+2
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see how well DAILIES TOTAL1 daily disposable contact lenses work for people who use digital devices a lot (at least eight hours a day). They will focus on how comfortable the

Who is the study for?
This trial is for people aged 18-40 who use digital devices like smartphones or computers for at least 8 hours a day. They must be current daily wearers of soft contact lenses, have near-sightedness within specific limits, and can commit to wearing DAILIES TOTAL1 contacts for over 13 hours daily.
What is being tested?
The study tests the performance of DAILIES TOTAL1 disposable contact lenses in individuals who frequently use digital screens. It focuses on comfort, dryness, and vision quality while using these lenses.
What are the potential side effects?
While not explicitly stated here, common side effects from wearing contact lenses may include eye discomfort or dryness, red eyes, blurry vision, and a feeling of something in the eye.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 14+2
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 14+2 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Subjective Rating of Clarity of Vision After 8 Hours or More of Digital Device Use
Subjective Rating of Comfort After 8 Hours or More of Digital Device Use
Subjective Rating of Dryness After 8 Hours or More of Digital Device Use

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: RefitExperimental Treatment1 Intervention
Refit and dispense participant with delefilcon A contact lenses and evaluate lens performance
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Delefilcon A contact lenses
2023
N/A
~1040

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
127 Previous Clinical Trials
214,797 Total Patients Enrolled
Alcon ResearchIndustry Sponsor
731 Previous Clinical Trials
128,793 Total Patients Enrolled
Lyndon Jones, PhD, FCOptomPrincipal InvestigatorCentre for Ocular Research & Education
12 Previous Clinical Trials
431 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top